Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study

INTRODUCTION: Clinical trials have shown that liraglutide effectively lowers glycated hemoglobin A1c (A1C) levels in adult patients with type 2 diabetes (T2D). However, no studies have evaluated the effectiveness of liraglutide by body mass index (BMI) in the United States (US) in clinical practice....

Descripción completa

Detalles Bibliográficos
Autores principales: Chitnis, Abhishek S., Ganz, Michael L., Benjamin, Nicole, Langer, Jakob, Hammer, Mette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176953/
https://www.ncbi.nlm.nih.gov/pubmed/25245811
http://dx.doi.org/10.1007/s12325-014-0153-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176953/
https://www.ncbi.nlm.nih.gov/pubmed/25245811
http://dx.doi.org/10.1007/s12325-014-0153-5

Ejemplares similares